You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,011,592


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,011,592
Title:Polycyclic inhibitor of anaplastic lymphoma kinase
Abstract: Disclosed is a polycyclic inhibitor of anaplastic lymphoma kinase as represented by Formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof. Also disclosed is a method for preparing the compound, a pharmaceutical preparation and a pharmaceutical composition comprising the compound, and use of the compound, the pharmaceutically acceptable salt or stereoisomer thereof in manufacture of a medicament for the treatment and/or prevention of, for example, an anaplastic lymphoma kinase-mediated cancer or non-cancer related diseases.
Inventor(s): Wu; Frank (Shandong, CN)
Assignee: XUANZHU PHARMA CO., LTD. (Jinan, Shandong Province, CN)
Application Number:15/515,056
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Patent Landscape and Claims for United States Patent 10,011,592

Introduction

Understanding the patent landscape and the specific claims of a patent is crucial for innovators, investors, and legal professionals. This analysis will delve into the broader context of the U.S. patent system and then focus on the specifics of United States Patent 10,011,592, highlighting key aspects, challenges, and implications.

The U.S. Patent System: An Overview

The U.S. patent system is a cornerstone of innovation and economic growth. However, it faces several challenges that affect its efficacy and reliability.

Importance of Intellectual Property

A robust intellectual property (IP) system is essential for fostering innovation and maintaining global competitiveness. It provides incentives for inventors and businesses to invest in research and development by offering exclusive rights to their inventions[1].

Current Challenges

The U.S. patent system is grappling with several issues, including unclear patent eligibility requirements, difficulties in enforcing patents, and the complexities of patent validity challenges.

Clarifying Patent Eligibility Requirements

The subject matter eligibility requirement under Section 101 of the U.S. Code has been a point of contention. The Supreme Court's decision in Alice v. CLS Bank introduced a two-part test that has been difficult to apply, leading to uncertainty for innovators and investors. Efforts such as the Patent Eligibility Restoration Act of 2022 aim to resolve this confusion but have not yet been successful[1].

Strengthening Patent Enforceability

The ability to enforce patents is critical, yet the Supreme Court's decision in eBay Inc. v. MercExchange, L.L.C. made it harder for patent holders to obtain injunctions. This has led to a situation where infringing companies may prefer to pay damages rather than cease using the patented technology[1].

Clarifying Patent Validity

The Leahy-Smith America Invents Act (AIA) of 2011 introduced administrative procedures like inter partes review (IPR) and post-grant review (PGR) to challenge patent validity. While these processes are faster and cheaper than court litigation, they have also raised concerns about undermining the patent system by making it too easy to challenge patents[2].

Patent 10,011,592: Specific Analysis

Background

To conduct a comprehensive analysis of United States Patent 10,011,592, one must first identify the invention, its claims, and the relevant prior art.

Invention Overview

Without specific details on the patent, a general approach would involve identifying the type of invention (e.g., utility, design, plant), its technical field, and the problems it addresses.

Claims Analysis

The claims of a patent define the scope of the invention and are crucial for determining its validity and enforceability.

Claim Construction

Each claim must be carefully constructed to meet the statutory requirements of novelty (Section 102), non-obviousness (Section 103), and subject matter eligibility (Section 101). The clarity and specificity of the claims can significantly impact the patent's strength and enforceability[1].

Prior Art Search

A thorough prior art search is essential to determine the novelty and non-obviousness of the invention. This involves searching global patent publications and non-patent literature to identify any existing inventions that may be similar or identical to the claimed invention[3].

Patentability Search

A patentability search, also known as a novelty search, is conducted to identify references that disclose the same or similar inventions. This helps in determining whether the claims should be revised to improve patentability.

Knock-out Patentability Search

This type of search compares the key features of the invention to relevant prior art to evaluate the strength of the invention and determine if claims need revision[3].

Validity Search

A validity search, or invalidity search, is crucial for assessing the validity of the patent. This involves a comprehensive global prior art search to identify any references that could potentially invalidate the patent claims.

Defending Against Infringement

For patent holders, a validity search helps in defending against infringement assertions by identifying potential weaknesses in the patent. For accused infringers, it provides a basis for challenging the patent's validity[3].

Challenges and Implications

National Security Considerations

For certain inventions, national security considerations come into play. The Invention Secrecy Act of 1951 mandates the review of patent applications that could be detrimental to national security if publicly disclosed. This process involves interagency reviews and potential secrecy orders[5].

Global Patent Landscape

The global patent landscape is increasingly interconnected. Tools like the Global Dossier and Common Citation Document (CCD) facilitate the integration of patent information across different jurisdictions, making it easier to manage and analyze patent families and prior art[4].

Economic and Technological Competitiveness

A strong IP system is vital for maintaining economic and technological competitiveness. The U.S. needs to address the current challenges in its patent system to ensure it remains a leader in innovation. This includes clarifying patent eligibility, strengthening patent enforceability, and improving the efficiency of patent validity challenges[1].

Key Takeaways

  • Clear Patent Eligibility Requirements: Unclear subject matter eligibility requirements create uncertainty and hinder innovation.
  • Effective Patent Enforceability: The ability to enforce patents is crucial; restoring the presumption of injunctions for patent infringement can help.
  • Efficient Patent Validity Challenges: The current administrative procedures need to balance efficiency with the need to protect patent rights.
  • Comprehensive Prior Art Search: Thorough searches are essential for ensuring the validity and enforceability of patents.
  • National Security Considerations: Certain inventions require careful review to ensure they do not compromise national security.

FAQs

Q: What are the main challenges facing the U.S. patent system?

A: The main challenges include unclear patent eligibility requirements, difficulties in enforcing patents, and the complexities of patent validity challenges.

Q: How does the Alice v. CLS Bank decision impact patent eligibility?

A: The decision introduced a two-part test that has been difficult to apply, leading to uncertainty for innovators and investors.

Q: What is the role of the Patent Trial and Appeal Board (PTAB) in challenging patent validity?

A: PTAB allows for administrative challenges to patent validity through inter partes review (IPR) and post-grant review (PGR), which are faster and cheaper than court litigation but have raised concerns about undermining the patent system.

Q: Why is a thorough prior art search important for patent applications?

A: A thorough prior art search helps determine the novelty and non-obviousness of the invention, ensuring that the patent claims are valid and enforceable.

Q: How do national security considerations affect patent applications?

A: Certain patent applications may be subject to secrecy orders if their disclosure could be detrimental to national security, involving interagency reviews and potential secrecy orders.

Sources

  1. Four Actions to Strengthen the U.S. Intellectual Property System - CSIS
  2. The Patent Trial and Appeal Board and Inter Partes Review - Congressional Research Service
  3. Patent Search Services - Clarivate
  4. Search for patents - USPTO
  5. Patent Security Reviews - Defense Technology Security Administration

More… ↓

⤷  Subscribe

Details for Patent 10,011,592

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 ⤷  Subscribe 2034-09-29
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 ⤷  Subscribe 2034-09-29
Genentech, Inc. AVASTIN bevacizumab Injection 125085 February 26, 2004 ⤷  Subscribe 2034-09-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.